- Title
- Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
- Creator
- Hua, Susan; Marks, Ellen; Schneider, Jennifer J.; Keely, Simon
- Relation
- Nanomedicine Vol. 11, Issue 5, p. 1117-1132
- Publisher Link
- http://dx.doi.org/10.1016/j.nano.2015.02.018
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2015
- Description
- Colon targeted drug delivery is an active area of research for local diseases affecting the colon, as it improves the efficacy of therapeutics and enables localized treatment, which reduces systemic toxicity. Targeted delivery of therapeutics to the colon is particularly advantageous for the treatment of inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease. Advances in oral drug delivery design have significantly improved the bioavailability of drugs to the colon; however in order for a drug to have therapeutic efficacy during disease, considerations must be made for the altered physiology of the gastrointestinal (GI) tract that is associated with GI inflammation. Nanotechnology has been used in oral dosage formulation design as strategies to further enhance uptake into diseased tissue within the colon. This review will describe some of the physiological challenges faced by orally administered delivery systems in IBD, the important developments in orally administered nano-delivery systems for colon targeting, and the future advances of this research.
- Subject
- colon targeted drug delivery; nano-delivery systems; oral administration; inflammatory bowel disease; colitis
- Identifier
- http://hdl.handle.net/1959.13/1323980
- Identifier
- uon:24935
- Identifier
- ISSN:1549-9642
- Language
- eng
- Reviewed
- Hits: 1175
- Visitors: 1318
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|